Speaker: Anthony Morandi, Executive Director Quality Site Head, Amgen, Inc.

Amgen leads the industry in innovative biotl1erapeutics with cutting edge technologies such as the world’s first bispecific therapeutic antibody (Blincyto), and the world’s first oncolytic virus (T-vec). Anthony Morandi will be discussing these technologies, and more, from the perspective of an insider who knows the history and developmental process. He will also be discussing recent innovations in bioprocessing that give Amgen’s Singapore facility unparalleled productivity and efficiency, and he has promised to share some of lus personal experiences as a industry scientist/ executive.